JDD Highlights
The September issue of the Journal of Drugs in Dermatology is available now. This month, we focus on aesthetic treatments, with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.
Read the September JDD Now
Aesthetics, Public Health, Anti-Aging, and Medical Dermatology
The September issue of the Journal of Drugs in Dermatology is available now. This month, we focus on aesthetic treatments, with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.
Article Highlights
- Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products in Melasma compares a HQ-free, retinol-free cosmetic topical brightener and HQ 4% in patients with skin types III-VI.
- Complication of Soft Tissue Fillers: Prevention and Management Review highlights the various adverse effects noted with the use of fillers and discusses prevention and management.
- There is a need for further evaluation of HA fillers for aesthetic use in Asia, where treatment goals may differ from western countries in Safety and Effectiveness of Hyaluronic Acid Fillers With Lidocaine for Full-Face Treatment in Asian Patients.
- Telangiectasia improvement with minimal downtime was assessed in Efficacy and Safety of Intense Pulsed Light With a KTP/PDL-like Filter for the Treatment of Facial Telangiectasias.
- Authors evaluate a cellulite treatment in Human Pharmacokinetics and Safety of Subcutaneous Collagenase Clostridium Histolyticum in Women.
Editor's Picks
-
Reconstruction of Cutaneous Defects of the Ear Using the Post-Auricular Reservoir: A Systematic Review illustrate the versatility of the post-auricular and mastoid skin reservoir for auricular repairs.
-
The Impact of Pharmacy Benefit Managers on Drug Pricing discusses what is behind the price of a medication that we see today.
You May Also Like
Addressing Estrogen Deficiency Skin Aging: A Non-Hormonal Approach Here is an insightful new study featured in the JDD! Intrinsic skin aging associated with estrogen deficiency presents a distinct therapeutic challenge…
Beyond AD and PN: Expanding Horizons for Interleukin-31 Blockade in Treatment-Refractory Pruritus Have you read this article from the JDD? Interleukin-31 receptor alpha targeting has established its place in our…
Unpacking clinical data on ingredient safety to separate viral fears from evidence-based facts Some of the most read topics in the JDD archive center on ingredient safety, and we want…
